Candel Therapeutics, Inc.CADLNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-27.04M
↓ 21% below average
Average (5y)
$-22.40M
Historical baseline
Range
High:$-5.34M
Low:$-34.70M
CAGR
+38.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-27.04M | +22.1% |
| 2023 | $-34.70M | -6.1% |
| 2022 | $-32.72M | -36.0% |
| 2021 | $-24.05M | -128.1% |
| 2020 | $-10.55M | -97.7% |
| 2019 | $-5.34M | - |